Insider · CIK 0001585084

Hagen Heidi

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001585084

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-03	OBXObsidian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.7K sh	—	—	37,653
2026-04-29	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+3,200 sh	—	—	35,050
2026-04-29	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	+3,200 sh	—	—	0
2026-04-29	VCELVericel Corp · Stock Option (Right to Buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2026-04-29	VCELVericel Corp · Restricted Stock UnitA Award	Director	AAward	+3,200 sh	—	—	3,200
2026-03-23	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$2.76	+$41.4K	46,850
2026-03-23	VCELVericel CorpS Sale	Director	SSale	−15K sh	$32.41	−$486K	31,850
2026-03-23	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	—	—	0
2025-04-30	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+3,200 sh	—	—	31,850
2025-04-30	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	+3,200 sh	—	—	0
2025-04-30	VCELVericel Corp · Stock Option (Right to Buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2025-04-30	VCELVericel Corp · Restricted Stock UnitA Award	Director	AAward	+3,200 sh	—	—	3,200
2025-03-03	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	$3.74	+$33.7K	37,650
2025-03-03	VCELVericel CorpS Sale	Director	SSale	−9,000 sh	$49.53	−$446K	28,650
2025-03-03	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	—	—	0
2024-10-17	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$3.74	+$15K	22,650
2024-10-17	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$3.74	+$22.4K	28,650
2024-10-17	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	0
2024-10-17	VCELVericel Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	—	—	9,000
2024-05-01	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+3,200 sh	—	—	18,650
2024-05-01	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	+3,200 sh	—	—	0
2024-05-01	VCELVericel Corp · Stock Option (Right to Buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2024-05-01	VCELVericel Corp · Restricted Stock UnitA Award	Director	AAward	+3,200 sh	—	—	3,200
2023-05-03	VCELVericel Corp · Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2023-05-03	VCELVericel Corp · Restricted Stock UnitA Award	Director	AAward	+3,200 sh	—	—	3,200
2023-04-27	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+2,600 sh	—	—	15,450
2023-04-27	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,600 sh	—	—	0
2022-04-27	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+2,600 sh	—	—	12,850
2022-04-27	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,600 sh	—	—	0
2022-04-27	VCELVericel Corp · Restricted Stock UnitA Award	Director	AAward	+2,600 sh	—	—	2,600
2022-04-27	VCELVericel Corp · Stock Option (right to buy)A Award	Director	AAward	+6,500 sh	—	—	6,500
2021-09-02	TCRTAlaunos Therapeutics, Inc.P Purchase	Director	PPurchase	+23.8K sh	$1.76	+$41.8K	145,889
2021-05-19	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$6.00	+$9,000	5,000
2021-05-19	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	$4.12	+$12.4K	8,000
2021-05-19	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+2,250 sh	$6.00	+$13.5K	10,250
2021-05-19	VCELVericel Corp · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	0
2021-05-19	VCELVericel Corp · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,250 sh	—	—	0
2021-05-19	VCELVericel Corp · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	0
2021-04-28	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+1,750 sh	—	—	3,500
2021-04-28	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,750 sh	—	—	0
2021-04-28	VCELVericel Corp · Stock Option (right to buy)A Award	Director	AAward	+6,500 sh	—	—	6,500
2021-04-28	VCELVericel Corp · Restricted Stock UnitA Award	Director	AAward	+2,600 sh	—	—	2,600
2021-03-04	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+90K sh	—	—	122,119
2021-03-04	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+675K sh	—	—	675,000
2020-04-29	VCELVericel CorpM Exercise/Conversion	Director	MExercise/Conversion	+1,750 sh	—	—	1,750
2020-04-29	VCELVericel Corp · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,750 sh	$14.56	−$25.5K	0
2020-04-29	VCELVericel Corp · Restricted Stock UnitA Award	Director	AAward	+1,750 sh	—	—	1,750
2020-04-29	VCELVericel Corp · Stock Option (right to buy)A Award	Director	AAward	+13.1K sh	—	—	13,125
2019-12-31	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+31.8K sh	—	—	32,119
2019-06-13	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+93.9K sh	—	—	93,922

Recent filings

Accepted (ET)
Aug 54
Hagen Heidi0001193125-26-335055
SEC(opens sec.gov)
May 14
Hagen Heidi0001140361-26-018543
SEC(opens sec.gov)
Mar 254
Hagen Heidi0001140361-26-011091
SEC(opens sec.gov)
May 24
Hagen Heidi0001140361-25-017118
SEC(opens sec.gov)
Mar 54
Hagen Heidi0001140361-25-007181
SEC(opens sec.gov)
Oct 214
Hagen Heidi0001140361-24-043798
SEC(opens sec.gov)
May 34
Hagen Heidi0001140361-24-024331
SEC(opens sec.gov)

Companies

Address

C/O OBSIDIAN THERAPEUTICS, INC. 1030 MASSACHUSETTS AVE

CAMBRIDGE, MA, 02138